You have read all your free articles, to continue reading subscribe to read the rest of this content.
In a small clinical trial just granted approval, about 30 COVID-19 patients at Karolinska University Hospital may soon begin to receive blood plasma from people who have recovered from the disease. Sweden’s Ethical Review Authority has approved the trial treatment, and its effectiveness will beAlready a subscriber Login You have…
Baricitinib, a drug against rheumatoid arthritis, could potentially be repurposed to treat patients with COVID-19, according to an international study conducted by among others researchers at Karolinska Institutet. Baricitinib is a once-daily oral drug used for treatment of adult patients with moAlready a subscriber Login You have read all your…
Swedish medtech start-up Capitainer has closed a share issue of SEK 31 million to roll out its new qDBS dried blood spot testing system. Led by Sciety the target was reached almost immediately after the pitch, primarily attracting both existing and new industry specialist investors. The investmenAlready a subscriber Login…
In view of the growing spread of the new coronavirus disease, T4M – Technology for Medical Devices is being postponed to 4–6 May 2021. "In setting a firm date, it is the aim of Messe Stuttgart, our supporters and close partners to deliver a trade fair to everyone involved that…
